Ozanezumab
Ozanezumab (GSK1223249) is an anti-Nogo-A (neurite outgrowth inhibitor A) monoclonal antibody. Ozanezumab can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research[1].
Product Specifications
CAS Number
1310680-64-8
Product Name Alternative
GSK1223249
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ozanezumab.html
Purity
99
Solubility
10 mM in DMSO
Smiles
[Ozanezumab]
Molecular Weight
(145.227 kDa)
References & Citations
[1]Meininger V, et al. Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2017 Mar;16 (3) :208-216.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2156428-01 96 Tests
Thrombin/Antithrombin Complex (TAT) Magnetic Fluorescence Assay Kit
Sign In for Pricing
View Details 
MBS2156428-02 5x 96 Tests
Thrombin/Antithrombin Complex (TAT) Magnetic Fluorescence Assay Kit
Sign In for Pricing
View Details MBS2156428-03 10x 96 Tests
Thrombin/Antithrombin Complex (TAT) Magnetic Fluorescence Assay Kit
Sign In for Pricing
View Details K0208505 3x 1.0 µg
C1orf85 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details